Cognate BioServices Is Now Part of Charles River

Cognate BioServices

In April 2021, Charles River acquired Cognate BioServices, the premier contract development and manufacturing organization for cell and gene-mediated cell therapy. Cognate, along with gene therapy CDMO providers Cobra Biologics and Vigene Biosciences, join Charles River to offer customers a single, trusted partner who has the insight and experience to take your cell and gene products from bench to bedside.

Connect With a Cell Therapy Specialist

 

Explore Our Cell and Gene Therapy CDMO Solutions

Stay Connected

Stay connected through this exciting transition by joining our mailing list. Sign up to keep in touch with our industry-leading scientists and receive news about our world-class products and services.

Sign up